Psychemedics Corporation (PMD)

2,6363 +0,0163 (+0,62%) Al cierre: 04:00PM EDT

Psychemedics Corporation

5220 Spring Valley Road
Suite 230
Dallas, TX 75254
United States
800 527 7424
https://www.psychemedics.com

Sector(es): Healthcare
Sector: Diagnostics & Research
Empleados a tiempo completo: 116

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Brian Hullinger	President, CEO & Director	361,37k	N/A	1968
Ms. Daniella Mehalik	Vice President of Finance	126,41k	N/A	1990
Ms. Shannon Shoemaker	Chief Revenue Officer	187,82k	N/A	N/A
Dr. Werner A. Baumgartner Ph.D.	Founder	N/A	N/A	N/A
Ms. Annette Baumgartner	Founder	N/A	N/A	N/A
Mr. Michael Weisenhoff	Principal Financial & Accounting Manager	N/A	N/A	1990
Mr. Patrick J. Kinney Jr.	Secretary	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas.

Gobierno corporativo

El ISS Governance QualityScore de Psychemedics Corporation, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.